IL10 and hepatocellular carcinoma: On the other hand, the decrease in serum IL-10 suggested that WCP against hepatocellular carcinoma might occur through an IL-10-regulated signaling pathway, so we examined its downstream STAT3 and p-STAT3 proteins.